Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Congenital Muscular Dystrophy Due to Lamin A/C Mutation”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Not applicableNo Longer AvailableNCT05154851
What this trial is testing

HBCMD01- Expanded Access for the Treatment of Congenital Muscular Dystrophy.

Who this might be right for
Congenital Muscular Dystrophy Due to Lamin A/C Mutation
Hope Biosciences Research Foundation
Large-scale testing (Phase 3)Ended earlyNCT03439514
What this trial is testing

ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation

Who this might be right for
Dilated CardiomyopathyLamin A/C Gene Mutation
Pfizer 77
Not applicableLooking for participantsNCT05394506
What this trial is testing

Modifying Factors in Striated Muscle Laminopathies

Who this might be right for
LaminopathiesEmery Dreifuss Muscular Dystrophy 2LMNA-Related Congenital Muscular Dystrophy+1 more
Institut National de la Santé Et de la Recherche Médicale, France 40